{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
ANDA075340
(1967)
Source URL:
First approved in 1967
Source:
ANDA075340
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333E
(2012)
Source URL:
First approved in 1967
Source:
NDA050805
Source URL:
Class (Stereo):
CHEMICAL (MIXED)
Status:
Possibly Marketed Outside US
Source:
M016
(2025)
Source URL:
First approved in 1967
Source:
M030
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333C
(1966)
Source URL:
First approved in 1966
Source:
21 CFR 333C
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
First approved in 1966
Source:
NADA141033
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Atipamezole is a synthetic α2-adrenergic antagonist. It competitively inhibits α2-adrenergic receptors. Atipamezole is indicated for the reversal of the sedative and analgesic effects of Dexdomitor and Domitor in dogs. Adverse reactions: occasional vomiting may occur. At times, a period of excitement or apprehensiveness may be seen in dogs treated with atipamezole. Other effects of atipamezole include hypersalivation, diarrhea, and tremors.
Status:
Possibly Marketed Outside US
First approved in 1965
Source:
NDA012806
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
A sorbitol derivative emulsifier used in many topical agents. Sorbitan Sesquioleate is used in a variety of products including skin care products, skin cleansing products, moisturizers, eye makeup and other makeup, primarily as an emollient. It is added to formulas as a skin soother and moisturizer and is derived from sorbitol, a humectant. Sorbitol sesquioleate (SSO) have recently been implicated in allergic dermatitis.
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2016)
Source URL:
First approved in 1965
Source:
M006
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333C
(2020)
Source URL:
First approved in 1965
Source:
ANDA074464
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(1995)
Source URL:
First approved in 1965
Source:
NDA006530
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
PEG-2 Stearate is a polyethylene glycol ester of stearic acid. The PEG Stearates are soft to waxy solids that are white to tan in color. In cosmetics and personal care products, PEG Stearates are used in skin creams, conditioners, shampoos, body cleansers and soapless detergents. PEG-2 Stearate had a potential for slight irritation in rabbits but was not a sensitizer in guinea pigs.
Status:
Possibly Marketed Outside US
Source:
21 CFR 358A
(1964)
Source URL:
First approved in 1964
Source:
21 CFR 358A
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Sodium dithionate is a very stable inorganic compound, which is not oxidized by permanganate, dichromate or bromine. The use of sodium dithionate is being criticized for the formation of non-environment friendly decomposition products such as sulphite, sulphate, thiosulphate and toxic sulphur.
